These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27871888)

  • 21. Impact of Experimental Conditions on the Evaluation of Interactions between Multidrug and Toxin Extrusion Proteins and Candidate Drugs.
    Lechner C; Ishiguro N; Fukuhara A; Shimizu H; Ohtsu N; Takatani M; Nishiyama K; Washio I; Yamamura N; Kusuhara H
    Drug Metab Dispos; 2016 Aug; 44(8):1381-9. PubMed ID: 27271370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal tubular secretion of pramipexole.
    Knop J; Hoier E; Ebner T; Fromm MF; Müller F
    Eur J Pharm Sci; 2015 Nov; 79():73-8. PubMed ID: 26360835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular determinants of ligand selectivity for the human multidrug and toxin extruder proteins MATE1 and MATE2-K.
    Astorga B; Ekins S; Morales M; Wright SH
    J Pharmacol Exp Ther; 2012 Jun; 341(3):743-55. PubMed ID: 22419765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OCT2 and MATE1 provide bidirectional agmatine transport.
    Winter TN; Elmquist WF; Fairbanks CA
    Mol Pharm; 2011 Feb; 8(1):133-42. PubMed ID: 21128598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Direction of Transport on the Evaluation of Inhibition Potencies of Multidrug and Toxin Extrusion Protein 1 Inhibitors.
    Saito A; Ishiguro N; Takatani M; Bister B; Kusuhara H
    Drug Metab Dispos; 2021 Feb; 49(2):152-158. PubMed ID: 33262224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of Human Multidrug and Toxic Compound Extrusion (MATE) Transporters in Testosterone Transport.
    Goda M; Ikehara M; Sakitani M; Oda K; Ishizawa K; Otsuka M
    Biol Pharm Bull; 2021; 44(4):501-506. PubMed ID: 33790101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of
    López Quiñones AJ; Wagner DJ; Wang J
    Mol Pharmacol; 2020 Aug; 98(2):109-119. PubMed ID: 32487736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple organic cation transporters contribute to the renal transport of sulpiride.
    Li L; Weng Y; Wang W; Bai M; Lei H; Zhou H; Jiang H
    Biopharm Drug Dispos; 2017 Dec; 38(9):526-534. PubMed ID: 28926871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wide variety of locations for rodent MATE1, a transporter protein that mediates the final excretion step for toxic organic cations.
    Hiasa M; Matsumoto T; Komatsu T; Moriyama Y
    Am J Physiol Cell Physiol; 2006 Oct; 291(4):C678-86. PubMed ID: 16641166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+.
    Thévenod F; Ciarimboli G; Leistner M; Wolff NA; Lee WK; Schatz I; Keller T; Al-Monajjed R; Gorboulev V; Koepsell H
    Mol Pharm; 2013 Aug; 10(8):3045-56. PubMed ID: 23763587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of human multidrug and toxin extrusion 1 is involved in the drug-drug interaction caused by cimetidine.
    Matsushima S; Maeda K; Inoue K; Ohta KY; Yuasa H; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2009 Mar; 37(3):555-9. PubMed ID: 19074525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Direction of Transport on the Evaluation of Substrate Recognition of Mouse Multidrug and Toxin Extrusion Protein 1.
    Saito A; Kito T; Ishiguro N; Takatani M; Kudo T; Bister B; Kusuhara H
    Drug Metab Dispos; 2023 May; 51(5):583-590. PubMed ID: 36669855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of human multidrug and toxin extrusion 1 (MATE1) transporter with antineoplastic agents.
    Grottker J; Rosenberger A; Burckhardt G; Hagos Y
    Drug Metabol Drug Interact; 2011; 26(4):181-9. PubMed ID: 22149660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction and Transport of Methamphetamine and its Primary Metabolites by Organic Cation and Multidrug and Toxin Extrusion Transporters.
    Wagner DJ; Sager JE; Duan H; Isoherranen N; Wang J
    Drug Metab Dispos; 2017 Jul; 45(7):770-778. PubMed ID: 28428365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function.
    Chen Y; Teranishi K; Li S; Yee SW; Hesselson S; Stryke D; Johns SJ; Ferrin TE; Kwok P; Giacomini KM
    Pharmacogenomics J; 2009 Apr; 9(2):127-36. PubMed ID: 19172157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation.
    Shen H; Liu T; Jiang H; Titsch C; Taylor K; Kandoussi H; Qiu X; Chen C; Sukrutharaj S; Kuit K; Mintier G; Krishnamurthy P; Fancher RM; Zeng J; Rodrigues AD; Marathe P; Lai Y
    Drug Metab Dispos; 2016 Feb; 44(2):238-49. PubMed ID: 26608080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indinavir Alters the Pharmacokinetics of Lamivudine Partially via Inhibition of Multidrug and Toxin Extrusion Protein 1 (MATE1).
    Li Q; Ye Z; Zhu P; Guo D; Yang H; Huang J; Zhang W; Polli JE; Shu Y
    Pharm Res; 2018 Jan; 35(1):14. PubMed ID: 29302757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a Double-Transfected System to Predict hOCT2/hMATE1-Mediated Renal Drug-Drug Interactions.
    Vieira LS; Wang J
    Drug Metab Dispos; 2024 Mar; 52(4):296-304. PubMed ID: 38326034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity.
    Kajiwara M; Terada T; Ogasawara K; Iwano J; Katsura T; Fukatsu A; Doi T; Inui K
    J Hum Genet; 2009 Jan; 54(1):40-6. PubMed ID: 19158817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cetirizine Reduces Gabapentin Plasma Concentrations and Effect: Role of Renal Drug Transporters for Organic Cations.
    Costa ACC; Yamamoto PA; Lauretti GR; de Lima Benzi JR; Zanelli CF; Barz V; Ciarimboli G; de Moraes NV
    J Clin Pharmacol; 2020 Aug; 60(8):1076-1086. PubMed ID: 32149389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.